Interpace Biosciences Inc (IDXG)
1.45
+0.05
(+3.57%)
USD |
OTCM |
May 10, 15:00
Interpace Biosciences Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| June 30, 2023 | -1.059M |
| March 31, 2023 | 1.641M |
| December 31, 2022 | 3.00M |
| September 30, 2022 | 4.37M |
| June 30, 2022 | 4.532M |
| March 31, 2022 | 5.001M |
| December 31, 2021 | 8.976M |
| September 30, 2021 | 7.66M |
| June 30, 2021 | 3.737M |
| March 31, 2021 | 3.468M |
| December 31, 2020 | 16.60M |
| September 30, 2020 | 23.05M |
| June 30, 2020 | 43.57M |
| March 31, 2020 | 41.31M |
| December 31, 2019 | 29.16M |
| September 30, 2019 | 22.77M |
| June 30, 2019 | 5.962M |
| March 31, 2019 | 6.006M |
| December 31, 2018 | -0.009M |
| September 30, 2018 | 5.866M |
| June 30, 2018 | 7.645M |
| March 31, 2018 | 19.22M |
| December 31, 2017 | 29.89M |
| September 30, 2017 | 23.91M |
| June 30, 2017 | 22.13M |
| Date | Value |
|---|---|
| March 31, 2017 | 10.57M |
| December 31, 2016 | -0.101M |
| September 30, 2016 | -21.32M |
| June 30, 2016 | -21.32M |
| March 31, 2016 | -21.33M |
| December 31, 2015 | -21.36M |
| September 30, 2015 | 19.39M |
| June 30, 2015 | 19.40M |
| March 31, 2015 | 19.40M |
| December 31, 2014 | 19.22M |
| September 30, 2014 | -0.284M |
| June 30, 2014 | -0.299M |
| March 31, 2014 | -0.302M |
| December 31, 2013 | -0.314M |
| September 30, 2013 | -0.276M |
| June 30, 2013 | -0.276M |
| March 31, 2013 | -0.278M |
| December 31, 2012 | -0.156M |
| September 30, 2012 | -0.13M |
| June 30, 2012 | -0.117M |
| March 31, 2012 | -0.112M |
| December 31, 2011 | -0.016M |
| September 30, 2011 | -0.036M |
| June 30, 2011 | -0.047M |
| March 31, 2011 | -0.049M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-1.059M
Minimum
Jun 2023
43.57M
Maximum
Jun 2020
13.16M
Average
5.962M
Median
Jun 2019
Cash from Financing (TTM) Benchmarks
| Fonar Corp | -8.460M |
| XWELL Inc | 0.008M |
| ProPhase Labs Inc | 5.757M |
| Applied DNA Sciences Inc | -0.0351M |
| Veracyte Inc | 0.288M |